Anugu, A.; Singh, P.; Kashyap, D.; Joseph, J.; Naik, S.; Sarkar, S.; Zaman, K.; Dhaliwal, M.; Nagar, S.; Gupta, T.;
et al. PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development. Microorganisms 2025, 13, 1557.
https://doi.org/10.3390/microorganisms13071557
AMA Style
Anugu A, Singh P, Kashyap D, Joseph J, Naik S, Sarkar S, Zaman K, Dhaliwal M, Nagar S, Gupta T,
et al. PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development. Microorganisms. 2025; 13(7):1557.
https://doi.org/10.3390/microorganisms13071557
Chicago/Turabian Style
Anugu, Amith, Pankaj Singh, Dharambir Kashyap, Jillwin Joseph, Sheetal Naik, Subhabrata Sarkar, Kamran Zaman, Manpreet Dhaliwal, Shubham Nagar, Tanishq Gupta,
and et al. 2025. "PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development" Microorganisms 13, no. 7: 1557.
https://doi.org/10.3390/microorganisms13071557
APA Style
Anugu, A., Singh, P., Kashyap, D., Joseph, J., Naik, S., Sarkar, S., Zaman, K., Dhaliwal, M., Nagar, S., Gupta, T., & Honnavar, P.
(2025). PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development. Microorganisms, 13(7), 1557.
https://doi.org/10.3390/microorganisms13071557
